NIZO contributes to the development of a COVID-19 detection test

NIZO contributes to the development of a quick and affordable test to detect infection by COVID-19

ViroTact is developing a unique, quick and affordable test (ViroTact© РCoviTact©) to detect infection by COVID-19 by detecting the presence of an essential virus-encoded protease in a patient sample. NIZO contributes to the development of this assay by providing mechanistic understanding of the mode of action of the essential virus-encoded protease in order to optimize the specificity and sensitivity of the assay. Read more.